From 2016 to 2021, real-world evidence (RWE) studies increased 162%. As investigators and regulators continue to embrace RWE, that number is expected to rise. If biopharma companies hope to stay competitive and achieve new, innovative therapies, they need to embrace RWE in their research.

Our latest infographic offers insights into how real-world evidence can answer biopharma’s most complex research questions. Learn why physician-led chart reviews and specialty provider networks are key to ensuring that RWE is pulled from the right comprehensive and research-grade data sources. Read now to learn more about:

• Physician-led chart reviews
• Utilizing specialty provider networks
• The potential benefits of RWE
• Getting started with the right provider network

​